RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy Market
Dec 2010 - 5 pages - $500
Orthopedic Biomaterials, The World Market
May 2011 - 250 pages - $3,995
Bone Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 43 pages - $1,000
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Musculoskeletal Disorders Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Bone Cancer Global Clinical Trials Review, H2, 2011
Aug 2011 - 109 pages - $1,000
Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents
Mar 2008 - 100 pages - $3,800
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
Bone Metastases Therapy Area Pipeline Report
Nov 2010 - 163 pages - $1,495
Nonmelanomatous Skin Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 47 pages - $1,000
More Related Market Research Reports >>>

Your selection

Therapeutic target
Musculoskeletal del
Bone cancer del
Development phase
Phase I del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us